z-logo
Premium
Current clinical diagnosis in Creutzfeldt‐Jakob disease: Identification of uncommon variants
Author(s) -
Zerr Inga,
SchulzSchaeffer Walter J.,
Giese Armin,
Bodemer Monika,
Schröter Andreas,
Henkel Karsten,
Tschampa Henriette J.,
Windl Otto,
Pfahlberg Annette,
Steinhoff Bernhard J.,
Gefeller Olaf,
Kretzschmar Hans A.,
Poser Sigrid
Publication year - 2000
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/1531-8249(200009)48:3<323::aid-ana6>3.0.co;2-5
Subject(s) - electroencephalography , pathology , magnetic resonance imaging , disease , hyperintensity , cerebrospinal fluid , phenotype , valine , medicine , biology , gene , genetics , neuroscience , amino acid , radiology
According to the recently established molecular basis for phenotypic heterogeneity of sporadic Creutzfeldt‐Jakob disease (CJD), six different phenotypes are characterized by the size of the protease‐resistant fragment of the pathological prion protein (types 1 and 2) and homozygosity or heterozygosity for methionine or valine at codon 129 of the prion protein gene (designated by MM1, MM2, MV1, MV2, VV1, and VV2). In the present investigation, we analyzed the value of commonly used clinical tests (electroencephalogram [EEG], detection of 14‐3‐3 protein in cerebrospinal fluid [CSF], and hyperintensity of the basal ganglia in magnetic resonance imaging) for the clinical diagnosis in each CJD phenotype. The detection of periodic sharp and slow wave complexes in the EEG is reliable in the clinical diagnosis of MM1 and MV1 patients only. The CSF analysis for 14‐3‐3 protein showed high sensitivity in all analyzed subgroups with the exception of MV2 patients. Valine‐homozygous patients had a negative EEG, but most had detectable levels of neuronal proteins in the CSF. The sensitivity of the magnetic resonance imaging was 70%, irrespective of the subgroup, but was particularly reliable in the clinical diagnosis of MV2 patients. The widening spectrum of diagnostic techniques in CJD is not only useful in the increased accuracy of the clinical diagnosis but should also lead to the identification of more atypical cases of sporadic CJD. Ann Neurol 2000;48:323–329

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here